Cardiothoracic Surgery
From the Journals
Infective endocarditis with stroke after TAVR has ‘dismal’ prognosis
News
OCS heart system earns hard-won backing of FDA panel
The nonbinding vote moves forward the device, which advocates hailed as a potentially transformative step for heart transplantation.
From the Journals
TAVR feasible, comparable with surgery in rheumatic heart disease
The largest study to date “opens the door to the massive unmet clinical needs in poorer regions as well as emerging economies,” an observer said...
From the Journals
COVID-19 case fatality doubled in heart transplant patients
Heart recipients are more vulnerable to SARS-CoV-2 infection and should be referred for specialist care, according to transplant experts from...
Conference Coverage
New-onset AFib common but unrecognized in the month after cardiac surgery
Results of SEARCH-AF trial show one in five cardiac surgery patients with no history of atrial fibrillation develop it within 30 days post...
Conference Coverage
Who’ll get SAVR in 2020?
SNOWMASS, COLO. – Surgical aortic valve replacement, anyone?
Conference Coverage
Opioid deaths boost donor heart supply
SNOWMASS, COLO. – The size of the donor heart pool for transplantation, flat for decades, is growing significantly.
Conference Coverage
Why STEMI patients benefit from PCI of nonculprit lesions
“This immediately explains the clinical benefit observed with preventive PCI in STEMI patients with multivessel disease.” – Dr. Frans Van de Werf...
Conference Coverage
Health benefits of TAVR over SAVR sustained at 1 year
SAN FRANCISCO – This marks the first randomized trial to show a persistent, albeit modest, disease-specific health status advantage with TAVR at 6...
Conference Coverage
Volume directly tied to mitral valve procedure success
SAN FRANCISCO – The magic number for physicians is 35 cases per year.